Company Filing History:
Years Active: 2019-2020
Title: The Innovative Contributions of Cecile Jacovetti
Introduction
Cecile Jacovetti is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biomedical research, particularly in the development of treatments for obesity and diabetes. With a total of 2 patents, her work has the potential to impact many lives.
Latest Patents
Cecile Jacovetti's latest patents focus on compositions and methods for measuring neuromedin U (NMU) and for treatment using anti-NMU agents. The inventors have produced two high specificity and high affinity monoclonal antibodies that bind to human NMU. These methods and compositions are designed to treat individuals in need, such as those who are obese or have diabetes, by administering an anti-NMU/NMUR agent. For instance, her work includes methods for increasing circulating insulin in individuals and detecting NMU in biological samples like serum. Additionally, her patents provide methods for predicting whether an individual will develop diabetes and/or pancreatic ductal adenocarcinoma (PDAC), as well as identifying individuals who would benefit from anti-NMU/NMUR agents.
Career Highlights
Cecile Jacovetti is affiliated with Leland Stanford Junior University, where she continues her research and innovation. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through her inventions.
Collaborations
Cecile has collaborated with notable colleagues, including Seung K Kim and Sangbin Park, to further her research initiatives and enhance the impact of her inventions.
Conclusion
Cecile Jacovetti's contributions to the field of biomedical research exemplify the power of innovation in addressing critical health issues. Her patents and ongoing work at Leland Stanford Junior University highlight her dedication to improving the lives of individuals affected by obesity and diabetes.